Neoplasm Metastases
19
3
3
11
Key Insights
Highlights
Success Rate
79% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
15.8%
3 terminated out of 19 trials
78.6%
-7.9% vs benchmark
0%
0 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (19)
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302)
Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas
Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)
Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)
Cognitive Outcome After Gamma Knife Radiosurgery in Patients With Brain Metastases (CAR-Study A)
Stereotactic Radiotherapy (SRT) Liver (COLD 1)
Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads
Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors
Comparing of Modified Wet Suction Technique and Dry Suction Technique for EUS-FNA of Solid Occupying Lesions
Neurocognition After Gamma Knife Radiosurgery for Multiple Brian Metastases
Oral Piroxicam Versus Buccal Fentanyl in Breakthrough Pain
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB and EUS-FNA on Solid Occupying Lesion
A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
Evaluate The Toxicity And Feasibility Of Intra-Tumoral Injection
Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.